expression through inhibition of p38 MAPK, JNK and AKT activation in human lung carcinoma cells. Biochem Pharmacol, 73: 215-227; 2007. Cosmetic Ingredient Review Expert Panel. Final report of the safety assessment of methacrylate ester monomers used in nail enhancement products. Int J Toxicol;2005; 24 Suppl 5:53-100 Darbre PD; Aljarrah A; Miller WR; Coldham NG; Sauer MJ; Pope GS Concentrations of parabens in human breast tumours. J Appl Toxicol; 2004; 24(1):5-13 De Dios A, Shih C, Lopez de Uralde B, Sanchez C, del Prado M, Martin Calbrejas LM, Pleite S, Blanco-Urgoiti J, Lorite MJ, Nevill CR Jr et al.: Design of potent and selective 2-aminobenzimidazole-based p38 MAP kinase inhibitors with excellent in vivo efficacy. J Med Chem, 48: 2270-2273; 2005. Delaney AM, Printen JA, Chen H, Fauman EB, Dudley DT: Identification of a novel mitogen-activated protein kinase kinase activation domain recognized by the inhibitor PD 184352. Mol Cell Biol, 22: 7593-7602; 2002. Felippe JJ. Cancer e acetazolamida . Revista Eletronica da Associacao Brasileira de Medicina Complementar. www.medicinacomplementar.com.br. Tema da semana de janeiro de 2008a. Felippe JJ Cancer e amiloride. Revista Eletronica da Associacao Brasileira de Medicina Complementar. www.medicinacomplementar.com.br. Tema da semana de janeiro de 2008b. Felippe JJ. Agua: vida saude envelhecimento doenca cancer .Revista Eletronica da Associacao Brasileira de Medicina Complementar. www.medicinacomplementar.com.br. Tema do mes de fevereiro de 2008c. Felippe JJ. Cancer e Tiosulfato de sodio : diminuicao da proliferacao celular do carcinoma epidermoide humano com um forte estruturador de clusters da agua intracelular.Revista Eletronica da Associacao Brasileira de Medicina Complementar. www.medicinacomplementar.com.br. Tema da semana de marco de 2008d Goldstein DM, Alfredson T, Bertrand J, Browner MF, Clifford K, Dalrymple SA, Dunn J, Freire-Moar J, Harris S, Labadie SS et al.: Discovery of S-(5-amino-1-(4-flurophenyl)-1H-pyrazol-4-yl)-(3-(2,3-dihydroxypropoxy) phenyl) methanone (RO3201195), an orally biovailable and highly selective inhibitor of p38 MAP kinase. J Med Chem, 49: 1562-1575; 2006. Goossens A; Armingaud P; Avenel-Audran M; Begon-Bagdassarian I; Constandt L; Giordano-Labadie F; Girardin P; Coz CJ; Milpied-Homsi B; Nootens C; Pecquet C; Tennstedt D; Vanhecke E. An epidemic of allergic contact dermatitis due to epilating products; Contact Dermatitis; 2002; 47(2):67-70 Handa O; Kokura S; Adachi S; Takagi T; Naito Y; Tanigawa T; Yoshida N; Yoshikawa T. Methylparaben potentiates UV-induced damage of skin keratinocytes. Toxicology;2006;227(1-2):62-72 Isidori M; Lavorgna M; Nardelli A; Parrella A. Toxicity on crustaceans and endocrine disrupting activity on Saccharomyces cerevisiae of eight alkylphenols;Chemosphere;2006; 64(1):135-43 Kim AL, Zhu Y, Zhu H, Han L, Kopelovich L, Bickers DR, Athar M: Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK 1 and AP-1 signalling pathways. Exp Dermatol, 15: 538-546; 2006. Kirkwood KL, Li F, Rogers JE, Otremba J, coatney DD, Kreider JM, DSilva NJ, Chakravarty S, Dugar S, Linda HS et al.: A p38 selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss. J Pharmacol Exp Ther, 320: 56-63; 2007. Kohno M, Pouyssegur J: Targeting the ERK signaling pathway in cancer therapy. Ann Med, 38: 200-211; 2006. Kolch W: Coordinating ERK/MAPK signaling through scaffolds and inhibitors. Nat Rev Mol Cell Biol, 6: 827-837; 2005. La Guardia MJ; Hale RC; Harvey E; Mainor TM. Alkylphenol ethoxylate degradation products